Bethesda, Md. (Sept. 19, 2011) – When researchers discovered the primary genetic defect that causes cystic fibrosis (CF) back in 1989, they opened up a new realm of research into treatment and a cure ...
VPO-227 is a small molecule with a novel mechanism of action, which blocks the cystic fibrosis transmembrane conductance regulator (CFTR) ion channel.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback